GCSAM Recombinant Antibody, Cy7 Conjugated
Product Specifications
Background
Involved in the negative regulation of lymphocyte motility. It mediates the migration-inhibitory effects of IL6. Serves as a positive regulator of the RhoA signaling pathway. Enhancement of RhoA activation results in inhibition of lymphocyte and lymphoma cell motility by activation of its downstream effector ROCK. Is a regulator of B-cell receptor signaling, that acts through SYK kinase activation.
Synonyms
GCAT2; Gcet; Gcsam; hGAL; M17; M17 L.
Gene ID
257144
Swiss Prot
Q8N6F7
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
GCSAM
Clonality
Recombinant
Conjugation
Cy7
Source
KLH conjugated synthetic peptide derived from human GCSAM
Applications
IF, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
743nm/767nm
Concentration
Lot dependent
Dilution
IF (), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
257144
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6171873-01 0.1 mL
STK32A (Serine/Threonine Kinase 32A, MGC22688, YANK1) (Biotin)
Sign In for Pricing
View Details MBS6171873-02 5x 0.1 mL
STK32A (Serine/Threonine Kinase 32A, MGC22688, YANK1) (Biotin)
Sign In for Pricing
View Details 